|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,450.00 KRW | -6.71% |
|
-8.44% | -34.75% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/25/12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.71% | -8.44% | -16.51% | -40.51% | -34.75% | -51.74% | - | - | - | 7.05Cr | |
| +1.09% | -3.84% | +28.68% | +35.16% | +19.12% | +70.10% | +437.29% | +134.24% | +2,146.01% | 3.91TCr | |
| -0.05% | -2.71% | +3.95% | +4.73% | +10.28% | +10.84% | +30.67% | -1.08% | +103.59% | 2.27TCr | |
| +2.29% | -2.06% | +7.37% | +6.57% | -5.31% | -21.43% | -40.04% | -44.88% | -2.24% | 717.49Cr | |
| -3.49% | -8.14% | +11.64% | +12.59% | -11.27% | +14.11% | +106.96% | +85.55% | +1,020.53% | 497.83Cr | |
| +0.70% | +3.33% | +7.48% | +20.80% | +17.15% | +19.88% | +47.40% | +0.33% | +255.92% | 301.11Cr | |
| -2.73% | -7.32% | +6.56% | +4.71% | -50.91% | -22.66% | +818.71% | -84.27% | - | 189.56Cr | |
| -1.17% | +4.12% | +2.17% | +9.42% | +27.57% | +33.47% | -21.11% | -41.41% | -40.14% | 182.23Cr | |
| 0.00% | -6.93% | +26.55% | +76.38% | +19.98% | +94.35% | -18.81% | -68.78% | +50.75% | 183.73Cr | |
| -1.64% | +3.19% | +6.39% | -6.43% | +7.67% | +27.97% | +4.06% | -32.14% | +12.52% | 171.23Cr | |
| +4.87% | +8.62% | +2.14% | -2.09% | -8.96% | -8.86% | -66.49% | -80.62% | - | 176.41Cr | |
| -1.44% | +2.20% | +6.67% | +34.82% | +29.01% | +34.14% | +197.11% | - | - | 149.3Cr | |
| -0.57% | -1.54% | +6.41% | +22.14% | +17.10% | +19.81% | +58.42% | -19.61% | - | 122.33Cr | |
| +0.24% | -3.40% | +3.33% | +6.99% | -0.89% | +5.24% | +22.29% | +17.33% | -30.17% | 113.3Cr | |
| -8.89% | -18.00% | -13.38% | +5.13% | -2.38% | -8.89% | -41.15% | -66.39% | -87.20% | 93Cr | |
| +5.31% | +0.98% | +0.25% | +34.74% | +20.40% | +38.80% | +195.70% | +20.03% | +196.96% | 85Cr | |
| -0.14% | -0.68% | +0.14% | -8.68% | -5.96% | +7.40% | +27.23% | -5.84% | +45.49% | 84Cr | |
| -2.36% | -4.61% | +4.06% | -10.66% | -3.46% | -13.73% | -48.41% | -69.23% | - | 77Cr | |
| +0.53% | -5.02% | +20.59% | +47.15% | +20.59% | +514.05% | +2,369.57% | - | - | 63Cr | |
| +2.99% | -4.72% | +26.20% | -10.32% | -0.69% | +41.13% | +8.38% | - | - | 60Cr | |
| Average | -0.57% | -1.88% | +7.03% | +12.13% | +3.22% | +40.20% | +215.15% | -16.05% | +306.00% | 472.49Cr | |
| Weighted average by Cap. | +0.36% | -2.86% | +15.49% | +20.44% | +10.65% | +38.42% | +228.08% | +50.83% | +1,071.25% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
